JPMorgan downgrades Comerica (NYSE:CMA) to Neutral rating
JPMorgan analyst Steven Alexopoulos downgrades Comerica (NYSE:CMA) from Overweight to Neutral.
JPMorgan downgrades Comerica (NYSE:CMA) to Neutral rating Read Post »
JPMorgan
JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorgan Chase had $3.9 trillion in assets and $317 billion in stockholders’ equity as of September 30, 2023. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world’s most prominent corporate, institutional and government clients globally.
Morgan Stanley lowered JPMorgan Chase (NYSE:JPM) price target to $153
Morgan Stanley analyst Betsy Graseck maintains JPMorgan Chase (NYSE:JPM) with a Overweight and lowers the price target from $173 to $153.
Morgan Stanley lowered JPMorgan Chase (NYSE:JPM) price target to $153 Read Post »
JPMorgan raised Ross Stores (NASDAQ:ROST) price target from $123 to $124
JPMorgan analyst Matthew Boss maintains Ross Stores (NASDAQ:ROST) with a Overweight and raises the price target from $123 to $124.
JPMorgan raised Ross Stores (NASDAQ:ROST) price target from $123 to $124 Read Post »
JPMorgan raised Regeneron Pharmaceuticals (NASDAQ:REGN) price target from $900 to $950
JPMorgan analyst Chris Schott maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price target from $900 to $950.
JPMorgan raised Regeneron Pharmaceuticals (NASDAQ:REGN) price target from $900 to $950 Read Post »
JPMorgan raised Marsh & McLennan (NYSE:MMC) price target from $180 to $181
JPMorgan analyst Jimmy Bhullar maintains Marsh & McLennan (NYSE:MMC) with a Neutral and raises the price target from $180 to $181.
JPMorgan raised Marsh & McLennan (NYSE:MMC) price target from $180 to $181 Read Post »
JPMorgan raised Progressive (NYSE:PGR) price target from $130 to $132
JPMorgan analyst Jimmy Bhullar maintains Progressive (NYSE:PGR) with a Neutral and raises the price target from $130 to $132.
JPMorgan raised Progressive (NYSE:PGR) price target from $130 to $132 Read Post »
JPMorgan raised Chubb (NYSE:CB) price target from $239 to $241
JPMorgan maintains Chubb (NYSE:CB) with a Overweight and raises the price target from $239 to $241.
JPMorgan raised Chubb (NYSE:CB) price target from $239 to $241 Read Post »
JPMorgan raised Philip Morris Intl (NYSE:PM) price target from $109 to $116
JPMorgan analyst Jared Dinges upgrades Philip Morris Intl (NYSE:PM) from Neutral to Overweight and raises the price target from $109 to $116.
JPMorgan raised Philip Morris Intl (NYSE:PM) price target from $109 to $116 Read Post »
JPMorgan raised Marathon Petroleum (NYSE:MPC) price target from $137 to $149
JPMorgan analyst John Royall downgrades Marathon Petroleum (NYSE:MPC) from Overweight to Neutral and raises the price target from $137 to $149.
JPMorgan raised Marathon Petroleum (NYSE:MPC) price target from $137 to $149 Read Post »
JPMorgan Chase (NYSE:JPM) to Post Q1 2023 Earnings of $3.14 Per Share, Oppenheimer Forecasts
Oppenheimer analyst C. Kotowski now expects that JPMorgan Chase (NYSE:JPM) to Post Q1 2023 Earnings of $3.14 Per Share for the quarter, down from their prior forecast of $3.20. Oppenheimer currently has a “Outperform” rating and a $157.00 target price on the stock.
JPMorgan Adjusts New York Times’ (NYSE:NYT) Price Target to $41 From $38
JPMorgan Adjusts New York Times’ (NYSE:NYT) Price Target to $41 From $38, Keeps Overweight Rating
JPMorgan Adjusts New York Times’ (NYSE:NYT) Price Target to $41 From $38 Read Post »
JPMorgan Adjusts Price Target on Sysco (NYSE:SYY) to $83 From $84
JPMorgan Adjusts Price Target on Sysco (NYSE:SYY) to $83 From $84, Maintains Overweight Rating.
JPMorgan Adjusts Price Target on Sysco (NYSE:SYY) to $83 From $84 Read Post »